Viking Therapeutics (NASDAQ:VKTX) Earns Buy Rating from HC Wainwright
Viking Therapeutics (NASDAQ:VKTX – Get Free Report)‘s stock had its “buy” rating reissued by stock analysts at HC Wainwright in a research note issued on Thursday,Benzinga reports. They currently have a $102.00 price target on the biotechnology company’s stock. HC Wainwright’s target price would indicate a potential upside of 308.16% from the company’s current price. […]
Viking Therapeutics (NASDAQ:VKTX – Get Free Report)‘s stock had its “buy” rating reissued by stock analysts at HC Wainwright in a research note issued on Thursday,Benzinga reports. They currently have a $102.00 price target on the biotechnology company’s stock. HC Wainwright’s target price would indicate a potential upside of 308.16% from the company’s current price. […]
